🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A recent review in our SLAS Technology comprehensively covers how AI is applied at every step of drug development, from target identification to patient stratification. #ArtificialIntelligence #Pharmaceutical #PrecisionMedicine #SLAS journals.sagepub.com/doi/abs/10.117…

Good things happen when engineering principles are applied to cancer research and drug development. Enjoyed this review by Ali Khademhosseini about AI/Engineering applied towards IO. #ArtificialIntelligence #oncology #Immunotherapy onlinelibrary.wiley.com/doi/full/10.10…

Free registration is open for the virtual CSI Singapore Frontiers in Cancer Science Annual Conference, Nov 2-6. We are partnering with FCS to organize three AACR-FCS Education Sessions for graduate students and early-career investigators. Learn more: nus.edu/2HJMeBq

ICYMI: The NADIM study: #Neoadjuvant #chemotherapy and #nivolumab in resectable non-small-cell #lungcancer: an open-label, multicentre, single-arm, phase 2 trial #NSCLC #lcsm thelancet.com/journals/lanon…

Check out our recent paper in Adv. Mat. on non-genetic modifications of cells by depositing nano-complexes of biomomecules on cell surfaces. Anti-PDL1 nano-complexes on macrophages markedly improved tumor response in mice doi.org/10.1002/adma.2… Wyss Institute Harvard SEAS

The Epigenetics in Cancer Symposium (15-17 Feb 2021) is a high profile conference with a lineup of internationally distinguished speakers. Registration is now open: cutt.ly/2hqOAIR More info available here: cutt.ly/LhqOPl3 Dennis Kappei @DefossezPierre

Abstract submission is now OPEN for the Epigenetics in Cancer Symposium 2021! Find out more here: rb.gy/hkutsw Register today at: rb.gy/9bhdij

It was a privilege working with an amazing team on this paper Trends in Biotechnology! The Institute for Digital Medicine (WisDM) The N.1 Institute for Health (N.1) NUSBME Chng Wee Joo @PersonalizedMed Ali Zarrinpar Edward Chow

Do not miss the opportunity to present your research at the Epigenetics in Cancer Symposium 2021! Abstract submission closes on 28 December. Submit your abstract today! csi.nus.edu.sg/web/epigenetic…

Our bond free premium scholarship provides you with the opportunity to work with a dynamic team of renowned scientists in an intellectually stimulating environment. Apply for the CSI PhD Graduate Program now! csi.nus.edu.sg/web/graduate-p…

DEADLINE EXTENDED! The closing date for abstract submission has been extended to 11 January 2021. Submit your abstracts today: csi.nus.edu.sg/web/epigenetic…

Super proud of our first publication of 2021! MYC synthetic lethality and how AI can improve synthetic lethal drug combination design.#Cancer #medicine #AI cell.com/trends/pharmac…

Hilarious. Cambridge flashbacks Roger Foo?

Really chuffed to have our work accepted as an oral presentation at #ASH2021 ash.confex.com/ash/2021/webpr… We report our clinical experience with #personalized combination treatments in relapsed #lymphoma - a fantastic collaboration with Edward Chow and colleagues across Singapore.

Great work led by Chester Drum

Is #personalization of drug combinations possible/ feasible in cancer care? Check out our latest publication in Science Translational Medicine: science.org/doi/10.1126/sc…. Fantastic collaboration with Edward Chow and clinical/ scientific colleagues Yong Loo Lin School of Medicine SingHealth CSI Singapore 1/n